Cutler Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Cutler Group’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-281	Closed	-$14K	–	6454
2020 Q4	$14K	Sell	281 -806	-74%	-$37.8K	﹤0.01%	2957
2020 Q3	$55K	Buy	+1,087	New	+$45.4K	﹤0.01%	1744

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Cutler Group's AXNX Position: Q1 2021 in Review

Cutler Group sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2021, closing a stake of 281 shares — an estimated $14K sold.

Cutler Group first reported a position in AXNX in Q3 2020 and held it in 2 quarters. The position peaked at $55K in Q3 2020. 160 funds tracked by Wall St. Rank hold AXNX as of Q1 2021.

Cutler Group reported no remaining Axonics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Cutler Group sold 281 Axonics, Inc. Common Stock shares in Q1 2021, an estimated $14K.
Cutler Group first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
Cutler Group's Axonics, Inc. Common Stock position peaked at $55K in Q3 2020.
160 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.